X-71911354-C-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001013627.3(NHSL2):​c.267C>A​(p.Asp89Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,087,230 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000014 ( 0 hom. 7 hem. )

Consequence

NHSL2
NM_001013627.3 missense

Scores

1
1
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.553

Publications

0 publications found
Variant links:
Genes affected
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.075014204).
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.267C>A p.Asp89Glu missense_variant Exon 1 of 8 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSL2ENST00000633930.2 linkc.267C>A p.Asp89Glu missense_variant Exon 1 of 8 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1
ENSG00000300926ENST00000775127.1 linkn.58+566G>T intron_variant Intron 1 of 2
ENSG00000300926ENST00000775128.1 linkn.235+353G>T intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000445
AC:
5
AN:
112245
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000461
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000407
AC:
2
AN:
49103
AF XY:
0.000119
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000167
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000144
AC:
14
AN:
974942
Hom.:
0
Cov.:
30
AF XY:
0.0000233
AC XY:
7
AN XY:
300138
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
21698
American (AMR)
AF:
0.000509
AC:
11
AN:
21619
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15876
East Asian (EAS)
AF:
0.00
AC:
0
AN:
23919
South Asian (SAS)
AF:
0.00
AC:
0
AN:
40675
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
23840
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2865
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
783423
Other (OTH)
AF:
0.0000731
AC:
3
AN:
41027
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000445
AC:
5
AN:
112288
Hom.:
0
Cov.:
24
AF XY:
0.0000579
AC XY:
2
AN XY:
34528
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31039
American (AMR)
AF:
0.000461
AC:
5
AN:
10853
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3466
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2729
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6148
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
211
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53000
Other (OTH)
AF:
0.00
AC:
0
AN:
1535
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000200

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 21, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.267C>A (p.D89E) alteration is located in exon 1 (coding exon 1) of the NHSL2 gene. This alteration results from a C to A substitution at nucleotide position 267, causing the aspartic acid (D) at amino acid position 89 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_noAF
Benign
-0.80
CADD
Benign
13
DANN
Benign
0.80
DEOGEN2
Benign
0.0088
T
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.40
T
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.075
T
MetaSVM
Benign
-1.0
T
PhyloP100
0.55
PrimateAI
Pathogenic
0.81
D
Sift4G
Benign
1.0
T
Vest4
0.25
MutPred
0.10
Gain of helix (P = 0.0082);
GERP RS
1.8
gMVP
0.032

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs960326758; hg19: chrX-71131204; API